California-based genetic products maker Affymetrix Inc. (NASDAQ:AFFX) reported third-quarter fiscal 2010 adjusted net loss per share of 4 cents, lower than the Zacks Consensus Estimate of a loss of 6 cents. The adjusted loss excludes one-time items including a $4.1 million gain on repurchase of convertible notes. Affymetrix posted a net income (on a reported [...]